Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaspar Taroncher-Oldenburg

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Nature Biotechnology|October 11, 2008
Trends in biotech literature 2007Gaspar Taroncher-Oldenburg, Andrew Marshall
Nature Biotechnology|September 12, 2007
Trends in biotech literature 2006Gaspar Taroncher-Oldenburg, Andrew Marshall
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2007
Oligonucleotide microarrays for the study of coastal microbial communitiesGaspar Taroncher-Oldenburg, Bess B Ward
Applied and Environmental Microbiology|February 7, 2003
Oligonucleotide microarray for the study of functional gene diversity in the nitrogen cycle in the environmentGaspar Taroncher-Oldenburg, Erin M Griner, Chris A Francis, et al.
Journal of Bacteriology|June 12, 2002
Genome-wide dynamic transcriptional profiling of the light-to-dark transition in Synechocystis sp. strain PCC 6803Ryan T Gill, Eva Katsoulakis, William Schmitt, et al.
Microorganisms|April 3, 2021
Targeting the DEAD-Box RNA Helicase eIF4A with Rocaglates-A Pan-Antiviral Strategy for Minimizing the Impact of Future RNA Virus PandemicsGaspar Taroncher-Oldenburg, Christin Müller, Wiebke Obermann, et al.
Antiviral Research|January 10, 2021
The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivoChristin Müller, Wiebke Obermann, Nadja Karl, et al.
Iscience|June 20, 2020
Integrating Systems Biology and an Ex Vivo Human Tumor Model Elucidates PD-1 Blockade Response DynamicsMunisha Smalley, Michelle Przedborski, Saravanan Thiyagarajan, et al.
Diabetes Care|May 26, 2016
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes OrganizationsFrancesco Rubino, David M Nathan, Robert H Eckel, et al.
Obesity Surgery|December 14, 2016
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes OrganizationsFrancesco Rubino, David M Nathan, Robert H Eckel, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Nature Biotechnology|October 11, 2008
Trends in biotech literature 2007Gaspar Taroncher-Oldenburg, Andrew Marshall
Nature Biotechnology|September 12, 2007
Trends in biotech literature 2006Gaspar Taroncher-Oldenburg, Andrew Marshall
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2007
Oligonucleotide microarrays for the study of coastal microbial communitiesGaspar Taroncher-Oldenburg, Bess B Ward
Applied and Environmental Microbiology|February 7, 2003
Oligonucleotide microarray for the study of functional gene diversity in the nitrogen cycle in the environmentGaspar Taroncher-Oldenburg, Erin M Griner, Chris A Francis, et al.
Journal of Bacteriology|June 12, 2002
Genome-wide dynamic transcriptional profiling of the light-to-dark transition in Synechocystis sp. strain PCC 6803Ryan T Gill, Eva Katsoulakis, William Schmitt, et al.
Microorganisms|April 3, 2021
Targeting the DEAD-Box RNA Helicase eIF4A with Rocaglates-A Pan-Antiviral Strategy for Minimizing the Impact of Future RNA Virus PandemicsGaspar Taroncher-Oldenburg, Christin Müller, Wiebke Obermann, et al.
Antiviral Research|January 10, 2021
The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivoChristin Müller, Wiebke Obermann, Nadja Karl, et al.
Iscience|June 20, 2020
Integrating Systems Biology and an Ex Vivo Human Tumor Model Elucidates PD-1 Blockade Response DynamicsMunisha Smalley, Michelle Przedborski, Saravanan Thiyagarajan, et al.
Diabetes Care|May 26, 2016
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes OrganizationsFrancesco Rubino, David M Nathan, Robert H Eckel, et al.
Obesity Surgery|December 14, 2016
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes OrganizationsFrancesco Rubino, David M Nathan, Robert H Eckel, et al.
Pageof 2